TreeWAS – Variant ID: rs154663

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N18 Chronic renal failure	0.191	0.809	0.000
N18.9 Chronic renal failure, unspecified	0.188	0.812	0.000
N18.0 End-stage renal disease	0.182	0.818	0.000
N18.3 Chronic kidney disease, stage 3	0.179	0.821	0.000
N18.4 Chronic kidney disease, stage 4	0.167	0.833	0.000
N18.5 Chronic kidney disease, stage 5	0.166	0.834	0.000
N18.8 Other chronic renal failure	0.150	0.850	0.000
N18.1 Chronic kidney disease, stage 1	0.131	0.869	0.000
Z09.0 Follow-up examination after surgery for other conditions	0.126	0.874	0.000
N18.2 Chronic kidney disease, stage 2	0.117	0.883	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.905	0.095
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.905	0.095
T39.0 Salicylates	0.000	0.910	0.090
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.913	0.087
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.916	0.084
T39.1 4-Aminophenol derivatives	0.000	0.916	0.084
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.916	0.084
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.917	0.083
N17-N19 Renal failure	0.082	0.918	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.919	0.081
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.919	0.080
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.920	0.080
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.921	0.079
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.922	0.078
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.925	0.075
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.926	0.074
T45.0 Antiallergic and antiemetic drugs	0.000	0.927	0.072
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.928	0.072
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.929	0.071
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.929	0.070
T46.1 Calcium-channel blockers	0.000	0.931	0.069
T39.4 Antirheumatics, not elsewhere classified	0.000	0.932	0.068
T39.2 Pyrazolone derivatives	0.000	0.932	0.068
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.932	0.068
T45.2 Vitamins, not elsewhere classified	0.000	0.932	0.068
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.932	0.068
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.933	0.067
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.933	0.067
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.934	0.066
T50.4 Drugs affecting uric acid metabolism	0.000	0.934	0.066
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.934	0.066
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.934	0.066
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.934	0.065
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.935	0.065
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.935	0.065
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.935	0.065
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.936	0.064
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.937	0.063
T47.6 Antidiarrhoeal drugs	0.000	0.937	0.063
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.937	0.062
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.938	0.062
T46.7 Peripheral vasodilators	0.000	0.938	0.062
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.938	0.062
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.938	0.062
T50.1 Loop [high-ceiling] diuretics	0.000	0.939	0.061
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.939	0.061
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.939	0.061
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.939	0.061
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.939	0.061
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.939	0.061
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.939	0.061
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.939	0.061
T44.0 Anticholinesterase agents	0.000	0.939	0.061
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.939	0.061
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.939	0.061
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.940	0.060
T47.4 Other laxatives	0.000	0.940	0.060
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.940	0.060
N19 Unspecified renal failure	0.060	0.940	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.940	0.060
T50.5 Appetite depressants	0.000	0.940	0.060
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.940	0.060
T50.0 Mineralocorticoids and their antagonists	0.000	0.940	0.060
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.940	0.059
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.941	0.059
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.941	0.059
T38.1 Thyroid hormones and substitutes	0.000	0.941	0.058
T43.9 Psychotropic drug, unspecified	0.000	0.942	0.058
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.942	0.058
T45.8 Other primarily systemic and haematological agents	0.000	0.942	0.058
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.942	0.058
T45.6 Fibrinolysis-affecting drugs	0.000	0.942	0.058
T45.3 Enzymes, not elsewhere classified	0.000	0.942	0.058
T43.6 Psychostimulants with abuse potential	0.000	0.942	0.058
N17 Acute renal failure	0.058	0.942	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.942	0.058
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.942	0.058
T47.7 Emetics	0.000	0.942	0.058
T47.5 Digestants	0.000	0.942	0.058
T47.3 Saline and osmotic laxatives	0.000	0.942	0.058
T45.4 Iron and its compounds	0.000	0.942	0.058
T47.2 Stimulant laxatives	0.000	0.942	0.058
T38.9 Other and unspecified hormone antagonists	0.000	0.943	0.057
T38.7 Androgens and anabolic congeners	0.000	0.943	0.057
T38.4 Oral contraceptives	0.000	0.943	0.057
T38.2 Antithyroid drugs	0.000	0.943	0.057
T38.5 Other oestrogens and progestogens	0.000	0.943	0.057
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.943	0.057
T45.5 Anticoagulants	0.000	0.945	0.055
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.946	0.054
T50.8 Diagnostic agents	0.000	0.946	0.054
T38.0 Glucocorticoids and synthetic analogues	0.000	0.946	0.054
T49.9 Topical agent, unspecified	0.000	0.946	0.053
T49.8 Other topical agents	0.000	0.946	0.053
T49.7 Dental drugs, topically applied	0.000	0.946	0.053
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.946	0.053
T49.5 Ophthalmological drugs and preparations	0.000	0.946	0.053
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.946	0.053
T49.3 Emollients, demulcents and protectants	0.000	0.946	0.053
T49.2 Local astringents and local detergents	0.000	0.946	0.053
T49.1 Antipruritics	0.000	0.946	0.053
T47.0 Histamine H(2)-receptor antagonists	0.000	0.947	0.052
T43.2 Other and unspecified antidepressants	0.000	0.948	0.052
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.948	0.052
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.949	0.051
T37.5 Antiviral drugs	0.000	0.949	0.051
T37.4 Anthelminthics	0.000	0.949	0.051
T37.3 Other antiprotozoal drugs	0.000	0.949	0.051
T37.1 Antimycobacterial drugs	0.000	0.949	0.051
T37.0 Sulphonamides	0.000	0.949	0.051
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.950	0.049
T41.5 Therapeutic gases	0.000	0.952	0.047
T41.4 Anaesthetic, unspecified	0.000	0.952	0.047
T41.3 Local anaesthetics	0.000	0.952	0.047
T41.1 Intravenous anaesthetics	0.000	0.952	0.047
T41.0 Inhaled anaesthetics	0.000	0.952	0.047
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.953	0.047
T48.4 Expectorants	0.000	0.953	0.047
T48.3 Antitussives	0.000	0.953	0.047
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.953	0.047
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.953	0.047
T48.0 Oxytocic drugs	0.000	0.953	0.047
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.954	0.046
T42.1 Iminostilbenes	0.000	0.954	0.046
T48.5 Anti-common-cold drugs	0.000	0.954	0.045
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.955	0.045
T41.2 Other and unspecified general anaesthetics	0.000	0.955	0.045
T36 Poisoning by systemic antibiotics	0.000	0.955	0.044
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.956	0.044
T42.2 Succinimides and oxazolidinediones	0.000	0.956	0.044
N17.1 Acute renal failure with acute cortical necrosis	0.044	0.956	0.000
T40.2 Other opioids	0.000	0.956	0.044
T42.4 Benzodiazepines	0.000	0.956	0.044
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.956	0.043
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.957	0.043
T42.3 Barbiturates	0.000	0.957	0.043
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.958	0.042
N17.2 Acute renal failure with medullary necrosis	0.042	0.958	0.000
N17.8 Other acute renal failure	0.041	0.959	0.000
N17.0 Acute renal failure with tubular necrosis	0.041	0.959	0.000
T42.0 Hydantoin derivatives	0.000	0.960	0.040
N17.9 Acute renal failure, unspecified	0.040	0.960	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.963	0.037
T40.8 Lysergide [LSD]	0.000	0.963	0.037
T40.7 Cannabis (derivatives)	0.000	0.963	0.037
T40.0 Opium	0.000	0.963	0.037
T40.1 Heroin	0.000	0.964	0.036
T40.3 Methadone	0.000	0.965	0.035
T40.5 Cocaine	0.000	0.966	0.033
T36.9 Systemic antibiotic, unspecified	0.000	0.968	0.032
T36.7 Antifungal antibiotics, systemically used	0.000	0.968	0.032
T36.6 Rifamycins	0.000	0.968	0.032
T36.5 Aminoglycosides	0.000	0.968	0.032
T36.2 Chloramphenicol group	0.000	0.968	0.032
T40.4 Other synthetic narcotics	0.000	0.968	0.032
T36.3 Macrolides	0.001	0.969	0.030
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.969	0.030
T36.8 Other systemic antibiotics	0.001	0.970	0.030
T36.4 Tetracyclines	0.001	0.970	0.029
T40.6 Other and unspecified narcotics	0.000	0.973	0.026
T36.0 Penicillins	0.001	0.976	0.023
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.978	0.022
F60.3 Emotionally unstable personality disorder	0.000	0.987	0.013
M17.9 Gonarthrosis, unspecified	0.012	0.988	0.000
I08.0 Disorders of both mitral and aortic valves	0.000	0.988	0.012
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.000	0.988	0.012
I08 Multiple valve diseases	0.000	0.988	0.012
C44.5 Skin of trunk	0.012	0.988	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.000	0.988	0.012
F60 Specific personality disorders	0.000	0.989	0.011
L57.0 Actinic keratosis	0.010	0.990	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.990	0.010
I08.2 Disorders of both aortic and tricuspid valves	0.000	0.990	0.010
F60.9 Personality disorder, unspecified	0.000	0.990	0.010
M13.99 Arthritis, unspecified (Site unspecified)	0.010	0.990	0.000
F60.0 Paranoid personality disorder	0.000	0.991	0.009
M13.95 Arthritis, unspecified (Pelvic region and thigh)	0.009	0.991	0.000
C44 Other malignant neoplasms of skin	0.009	0.991	0.000
I05-I09 Chronic rheumatic heart diseases	0.000	0.992	0.008
I08.8 Other multiple valve diseases	0.000	0.992	0.008
C44.0 Skin of lip	0.008	0.992	0.000
I08.9 Multiple valve disease, unspecified	0.000	0.992	0.008
C43.6 Malignant melanoma of upper limb, including shoulder	0.008	0.992	0.000
F60.4 Histrionic personality disorder	0.000	0.992	0.008
F60.1 Schizoid personality disorder	0.000	0.992	0.008
F60.6 Anxious [avoidant] personality disorder	0.000	0.992	0.008
M13.9 Arthritis, unspecified	0.008	0.992	0.000
F60.2 Dissocial personality disorder	0.000	0.992	0.008
F60.5 Anankastic personality disorder	0.000	0.992	0.008
F60-F69 Disorders of adult personality and behaviour	0.000	0.992	0.008
M13.97 Arthritis, unspecified (Ankle and foot)	0.008	0.992	0.000
F60.8 Other specific personality disorders	0.000	0.993	0.007
C44.7 Skin of lower limb, including hip	0.007	0.993	0.000
F60.7 Dependent personality disorder	0.000	0.993	0.007
I09 Other rheumatic heart diseases	0.000	0.993	0.007
C43 Malignant melanoma of skin	0.007	0.993	0.000
I05 Rheumatic mitral valve diseases	0.000	0.993	0.007
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.000	0.993	0.007
F69 Unspecified disorder of adult personality and behaviour	0.000	0.993	0.007
C79.2 Secondary malignant neoplasm of skin	0.000	0.993	0.007
I05.9 Mitral valve disease, unspecified	0.000	0.993	0.007
C43-C44 Melanoma and other malignant neoplasms of skin	0.007	0.993	0.000
I07 Rheumatic tricuspid valve diseases	0.000	0.993	0.007
M13.93 Arthritis, unspecified (Forearm)	0.007	0.993	0.000
I09.9 Rheumatic heart disease, unspecified	0.000	0.993	0.007
C44.9 Malignant neoplasm of skin, unspecified	0.006	0.993	0.000
C79 Secondary malignant neoplasm of other sites	0.000	0.993	0.007
C44.8 Overlapping lesion of skin	0.006	0.994	0.000
F64 Gender identity disorders	0.000	0.994	0.006
I06 Rheumatic aortic valve diseases	0.000	0.994	0.006
F61 Mixed and other personality disorders	0.000	0.994	0.006
C43.7 Malignant melanoma of lower limb, including hip	0.006	0.994	0.000
C44.1 Skin of eyelid, including canthus	0.006	0.994	0.000
C44.3 Skin of other and unspecified parts of face	0.006	0.994	0.000
R16.1 Splenomegaly, not elsewhere classified	0.000	0.994	0.006
C43.5 Malignant melanoma of trunk	0.006	0.994	0.000
F68 Other disorders of adult personality and behaviour	0.000	0.994	0.006
E89.0 Postprocedural hypothyroidism	0.006	0.994	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.000	0.994	0.006
F65 Disorders of sexual preference	0.000	0.994	0.006
F63 Habit and impulse disorders	0.000	0.994	0.006
F62 Enduring personality changes, not attributable to brain damage and disease	0.000	0.994	0.006
M13.96 Arthritis, unspecified (Lower leg)	0.006	0.994	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.006	0.994	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.005	0.994	0.000
I07.1 Tricuspid insufficiency	0.000	0.994	0.006
I09.8 Other specified rheumatic heart diseases	0.000	0.994	0.005
I09.2 Chronic rheumatic pericarditis	0.000	0.994	0.005
I09.1 Rheumatic diseases of endocardium, valve unspecified	0.000	0.994	0.005
I09.0 Rheumatic myocarditis	0.000	0.994	0.005
M13.92 Arthritis, unspecified (Upper arm)	0.005	0.994	0.000
C43.0 Malignant melanoma of lip	0.005	0.994	0.000
I05.8 Other mitral valve diseases	0.000	0.994	0.005
C43.8 Overlapping malignant melanoma of skin	0.005	0.995	0.000
H40.2 Primary angle-closure glaucoma	0.005	0.995	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.005	0.995	0.000
R06.5 Mouth breathing	0.000	0.995	0.005
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.995	0.005
F64.0 Transsexualism	0.000	0.995	0.005
C43.1 Malignant melanoma of eyelid, including canthus	0.005	0.995	0.000
M13 Other arthritis	0.005	0.995	0.000
I05.2 Mitral stenosis with insufficiency	0.000	0.995	0.005
I07.9 Tricuspid valve disease, unspecified	0.000	0.995	0.005
I07.8 Other tricuspid valve diseases	0.000	0.995	0.005
I07.2 Tricuspid stenosis with insufficiency	0.000	0.995	0.005
I07.0 Tricuspid stenosis	0.000	0.995	0.005
I05.0 Mitral stenosis	0.000	0.995	0.005
I05.1 Rheumatic mitral insufficiency	0.000	0.995	0.005
T79.3 Post-traumatic wound infection, not elsewhere classified	0.000	0.995	0.005
L57 Skin changes due to chronic exposure to nonionising radiation	0.005	0.995	0.000
I06.1 Rheumatic aortic insufficiency	0.000	0.995	0.005
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.995	0.005
C43.4 Malignant melanoma of scalp and neck	0.005	0.995	0.000
K81.0 Acute cholecystitis	0.000	0.995	0.005
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.995	0.005
C43.9 Malignant melanoma of skin, unspecified	0.005	0.995	0.000
C44.2 Skin of ear and external auricular canal	0.005	0.995	0.000
C44.6 Skin of upper limb, including shoulder	0.005	0.995	0.000
F64.9 Gender identity disorder, unspecified	0.000	0.995	0.005
F64.8 Other gender identity disorders	0.000	0.995	0.005
F64.2 Gender identity disorder of childhood	0.000	0.995	0.005
F64.1 Dual-role transvestism	0.000	0.995	0.005
I06.8 Other rheumatic aortic valve diseases	0.000	0.995	0.005
I06.0 Rheumatic aortic stenosis	0.000	0.995	0.004
I06.9 Rheumatic aortic valve disease, unspecified	0.000	0.995	0.004
H40 Glaucoma	0.005	0.995	0.000
H40.8 Other glaucoma	0.005	0.995	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.995	0.004
I06.2 Rheumatic aortic stenosis with insufficiency	0.000	0.995	0.004
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene	0.000	0.995	0.005
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.000	0.996	0.004
M13.1 Monoarthritis, not elsewhere classified	0.004	0.996	0.000
F63.9 Habit and impulse disorder, unspecified	0.000	0.996	0.004
F63.8 Other habit and impulse disorders	0.000	0.996	0.004
F63.3 Trichotillomania	0.000	0.996	0.004
F63.2 Pathological stealing [kleptomania]	0.000	0.996	0.004
F63.1 Pathological fire-setting [pyromania]	0.000	0.996	0.004
F63.0 Pathological gambling	0.000	0.996	0.004
F65.9 Disorder of sexual preference, unspecified	0.000	0.996	0.004
F65.8 Other disorders of sexual preference	0.000	0.996	0.004
F65.6 Multiple disorders of sexual preference	0.000	0.996	0.004
F65.5 Sadomasochism	0.000	0.996	0.004
F65.4 Paedophilia	0.000	0.996	0.004
F65.3 Voyeurism	0.000	0.996	0.004
F65.2 Exhibitionism	0.000	0.996	0.004
F65.1 Fetishistic transvestism	0.000	0.996	0.004
F65.0 Fetishism	0.000	0.996	0.004
F66.9 Psychosexual development disorder, unspecified	0.000	0.996	0.004
F66.8 Other psychosexual development disorders	0.000	0.996	0.004
F66.2 Sexual relationship disorder	0.000	0.996	0.004
F66.1 Egodystonic sexual orientation	0.000	0.996	0.004
F66.0 Sexual maturation disorder	0.000	0.996	0.004
F68.8 Other specified disorders of adult personality and behaviour	0.000	0.996	0.004
F68.0 Elaboration of physical symptoms for psychological reasons	0.000	0.996	0.004
F62.8 Other enduring personality changes	0.000	0.996	0.004
F62.1 Enduring personality change after psychiatric illness	0.000	0.996	0.004
F62.0 Enduring personality change after catastrophic experience	0.000	0.996	0.004
G25.0 Essential tremor	0.004	0.996	0.000
T79 Certain early complications of trauma, not elsewhere classified	0.000	0.996	0.004
M13.98 Arthritis, unspecified (Other)	0.004	0.996	0.000
M13.94 Arthritis, unspecified (Hand)	0.004	0.996	0.000
F62.9 Enduring personality change, unspecified	0.000	0.996	0.004
M13.8 Other specified arthritis	0.004	0.996	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.996	0.004
M13.91 Arthritis, unspecified (Shoulder region)	0.004	0.996	0.000
H40.1 Primary open-angle glaucoma	0.004	0.996	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.996	0.004
L57.5 Actinic granuloma	0.004	0.996	0.000
M13.16 Monoarthritis, not elsewhere classified (Lower leg)	0.004	0.996	0.000
M79.89 Other specified soft tissue disorders (Site unspecified)	0.000	0.996	0.004
C79.6 Secondary malignant neoplasm of ovary	0.000	0.996	0.004
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.004	0.996	0.000
L57.3 Poikiloderma of Civatte	0.004	0.996	0.000
L57.2 Cutis rhomboidalis nuchae	0.004	0.996	0.000
L57.1 Actinic reticuloid	0.004	0.996	0.000
T79.7 Traumatic subcutaneous emphysema	0.000	0.996	0.004
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.004	0.996	0.000
H40.5 Glaucoma secondary to other eye disorders	0.004	0.996	0.000
T79.8 Other early complications of trauma	0.000	0.996	0.004
M13.0 Polyarthritis, unspecified	0.004	0.996	0.000
H40.6 Glaucoma secondary to drugs	0.004	0.996	0.000
L57.4 Cutis laxa senilis	0.003	0.996	0.000
J90 Pleural effusion, not elsewhere classified	0.000	0.996	0.004
S32.50 Fracture of pubis (closed)	0.000	0.996	0.004
M13.89 Other specified arthritis (Site unspecified)	0.003	0.996	0.000
E89.3 Postprocedural hypopituitarism	0.003	0.996	0.000
H40.3 Glaucoma secondary to eye trauma	0.003	0.996	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.003	0.996	0.000
M13.19 Monoarthritis, not elsewhere classified (Site unspecified)	0.003	0.997	0.000
M13.18 Monoarthritis, not elsewhere classified (Other)	0.003	0.997	0.000
M13.17 Monoarthritis, not elsewhere classified (Ankle and foot)	0.003	0.997	0.000
M13.15 Monoarthritis, not elsewhere classified (Pelvic region and thigh)	0.003	0.997	0.000
M13.14 Monoarthritis, not elsewhere classified (Hand)	0.003	0.997	0.000
M13.13 Monoarthritis, not elsewhere classified (Forearm)	0.003	0.997	0.000
M13.12 Monoarthritis, not elsewhere classified (Upper arm)	0.003	0.997	0.000
M13.11 Monoarthritis, not elsewhere classified (Shoulder region)	0.003	0.997	0.000
M13.10 Monoarthritis, not elsewhere classified (Multiple sites)	0.003	0.997	0.000
M13.86 Other specified arthritis (Lower leg)	0.003	0.997	0.000
H40.9 Glaucoma, unspecified	0.003	0.997	0.000
E89.2 Postprocedural hypoparathyroidism	0.003	0.997	0.000
K55.9 Vascular disorder of intestine, unspecified	0.003	0.997	0.000
T79.5 Traumatic anuria	0.000	0.997	0.003
K05.3 Chronic periodontitis	0.003	0.997	0.000
M13.80 Other specified arthritis (Multiple sites)	0.003	0.997	0.000
T79.9 Unspecified early complication of trauma	0.000	0.997	0.003
T79.1 Fat embolism (traumatic)	0.000	0.997	0.003
T79.0 Air embolism (traumatic)	0.000	0.997	0.003
T79.2 Traumatic secondary and recurrent haemorrhage	0.000	0.997	0.003
M13.88 Other specified arthritis (Other)	0.003	0.997	0.000
M13.85 Other specified arthritis (Pelvic region and thigh)	0.003	0.997	0.000
M13.83 Other specified arthritis (Forearm)	0.003	0.997	0.000
M13.82 Other specified arthritis (Upper arm)	0.003	0.997	0.000
M13.81 Other specified arthritis (Shoulder region)	0.003	0.997	0.000
T79.4 Traumatic shock	0.000	0.997	0.003
M13.84 Other specified arthritis (Hand)	0.003	0.997	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.003	0.997	0.000
H40.4 Glaucoma secondary to eye inflammation	0.003	0.997	0.000
E89.5 Postprocedural testicular hypofunction	0.003	0.997	0.000
M17 Gonarthrosis [arthrosis of knee]	0.003	0.997	0.000
M13.87 Other specified arthritis (Ankle and foot)	0.003	0.997	0.000
T79.6 Traumatic ischaemia of muscle	0.000	0.997	0.003
T92.1 Sequelae of fracture of arm	0.000	0.997	0.003
M06.9 Rheumatoid arthritis, unspecified	0.003	0.997	0.000
Z09 Follow-up examination after treatment for conditions other than malignant neoplasms	0.003	0.997	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.003	0.997	0.000
E89.4 Postprocedural ovarian failure	0.003	0.997	0.000
M13.06 Polyarthritis, unspecified (Lower leg)	0.003	0.997	0.000
M13.04 Polyarthritis, unspecified (Hand)	0.003	0.997	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.003	0.997	0.000
M13.09 Polyarthritis, unspecified (Site unspecified)	0.003	0.997	0.000
G99.2 Myelopathy in diseases classified elsewhere	0.000	0.997	0.003
M13.08 Polyarthritis, unspecified (Other)	0.003	0.997	0.000
M13.07 Polyarthritis, unspecified (Ankle and foot)	0.003	0.997	0.000
M13.05 Polyarthritis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M13.03 Polyarthritis, unspecified (Forearm)	0.003	0.997	0.000
M13.02 Polyarthritis, unspecified (Upper arm)	0.003	0.997	0.000
M13.01 Polyarthritis, unspecified (Shoulder region)	0.003	0.997	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.003	0.997	0.000
E89.1 Postprocedural hypoinsulinaemia	0.003	0.997	0.000
G25 Other extrapyramidal and movement disorders	0.003	0.997	0.000
T79-T79 Certain early complications of trauma	0.000	0.997	0.003
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
R44.0 Auditory hallucinations	0.000	0.997	0.003
H40.0 Glaucoma suspect	0.003	0.997	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.000	0.997	0.003
N50.1 Vascular disorders of male genital organs	0.000	0.997	0.003
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.997	0.003
Z98.0 Intestinal bypass and anastomosis status	0.003	0.997	0.000
M17.2 Posttraumatic gonarthrosis, bilateral	0.003	0.997	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.997	0.003
M17.0 Primary gonarthrosis, bilateral	0.003	0.997	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.003	0.997	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.003	0.997	0.000
T92.9 Sequelae of unspecified injury of upper limb	0.000	0.997	0.003
T92 Sequelae of injuries of upper limb	0.000	0.997	0.003
G25.1 Drug-induced tremor	0.002	0.997	0.000
T83.1 Mechanical complication of other urinary devices and implants	0.000	0.997	0.003
M13.00 Polyarthritis, unspecified (Multiple sites)	0.002	0.997	0.000
M17.4 Other secondary gonarthrosis, bilateral	0.002	0.997	0.000
Z09.4 Follow-up examination after treatment of fracture	0.002	0.997	0.000
Z09.3 Follow-up examination after psychotherapy	0.002	0.997	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
Z09.1 Follow-up examination after radiotherapy for other conditions	0.002	0.998	0.000
S32.5 Fracture of pubis	0.000	0.998	0.002
S02.10 Fracture of base of skull (closed)	0.000	0.998	0.002
R44.1 Visual hallucinations	0.000	0.998	0.002
K50.0 Crohn's disease of small intestine	0.002	0.998	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.002	0.998	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.002	0.998	0.000
G25.4 Drug-induced chorea	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.000	0.998	0.002
J92.0 Pleural plaque with presence of asbestos	0.000	0.998	0.002
K65.8 Other peritonitis	0.002	0.998	0.000
Z09.7 Follow-up examination after combined treatment for other conditions	0.002	0.998	0.000
Z33 Pregnant state, incidental	0.000	0.998	0.002
G25.2 Other specified forms of tremor	0.002	0.998	0.000
M17.5 Other secondary gonarthrosis	0.002	0.998	0.000
S40.0 Contusion of shoulder and upper arm	0.000	0.998	0.002
S61.1 Open wound of finger(s) with damage to nail	0.000	0.998	0.002
S72.00 Fracture of neck of femur (closed)	0.000	0.998	0.002
G25.9 Extrapyramidal and movement disorder, unspecified	0.002	0.998	0.000
M75.0 Adhesive capsulitis of shoulder	0.000	0.998	0.002
G25.3 Myoclonus	0.002	0.998	0.000
K55.0 Acute vascular disorders of intestine	0.002	0.998	0.000
X63.0 Home	0.000	0.998	0.002
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.002	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
H90.2 Conductive hearing loss, unspecified	0.002	0.998	0.000
M06 Other rheumatoid arthritis	0.002	0.998	0.000
O16 Unspecified maternal hypertension	0.000	0.998	0.002
G25.5 Other chorea	0.002	0.998	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.000	0.998	0.002
K55 Vascular disorders of intestine	0.002	0.998	0.000
Z98.8 Other specified postsurgical states	0.002	0.998	0.000
J92 Pleural plaque	0.000	0.998	0.002
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
C44.4 Skin of scalp and neck	0.002	0.998	0.000
S32.51 Fracture of pubis (open)	0.000	0.998	0.002
R44 Other symptoms and signs involving general sensations and perceptions	0.000	0.998	0.002
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.998	0.002
K65.9 Peritonitis, unspecified	0.002	0.998	0.000
M17.3 Other posttraumatic gonarthrosis	0.002	0.998	0.000
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.000	0.998	0.002
T92.8 Sequelae of other specified injuries of upper limb	0.000	0.998	0.002
T92.4 Sequelae of injury of nerve of upper limb	0.000	0.998	0.002
H40-H42 Glaucoma	0.002	0.998	0.000
M05-M14 Inflammatory polyarthropathies	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.000	0.998	0.002
J90-J94 Other diseases of pleura	0.000	0.998	0.002
X60.1 Residential institution	0.000	0.998	0.002
Z85.5 Personal history of malignant neoplasm of urinary tract	0.000	0.998	0.002
L56 Other acute skin changes due to ultraviolet radiation	0.002	0.998	0.000
X60.8 Other specified place	0.000	0.998	0.002
X60.5 Trade and service area	0.000	0.998	0.002
M06.1 Adult-onset Still's disease	0.002	0.998	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.002	0.998	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.000	0.998	0.002
L58 Radiodermatitis	0.002	0.998	0.000
S40 Superficial injury of shoulder and upper arm	0.000	0.998	0.002
M06.8 Other specified rheumatoid arthritis	0.002	0.998	0.000
T92.0 Sequelae of open wound of upper limb	0.000	0.998	0.002
X60.9 Unspecified place	0.000	0.998	0.002
X60.0 Home	0.000	0.998	0.002
X60.7 Farm	0.000	0.998	0.002
X60.6 Industrial and construction area	0.000	0.998	0.002
X60.4 Street and highway	0.000	0.998	0.002
X60.3 Sports and athletics area	0.000	0.998	0.002
Z04.3 Examination and observation following other accident	0.000	0.998	0.002
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.000	0.998	0.002
Z98 Other postsurgical states	0.002	0.998	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.002	0.998	0.000
K82.9 Disease of gallbladder, unspecified	0.000	0.998	0.002
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.998	0.002
M06.2 Rheumatoid bursitis	0.002	0.998	0.000
Z91.5 Personal history of self-harm	0.000	0.998	0.002
J91 Pleural effusion in conditions classified elsewhere	0.000	0.998	0.002
X60-X84 Intentional self-harm	0.000	0.998	0.002
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.998	0.002
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.000	0.998	0.002
Z98.1 Arthrodesis status	0.002	0.998	0.000
L55 Sunburn	0.002	0.998	0.000
K55.1 Chronic vascular disorders of intestine	0.002	0.998	0.000
M06.4 Inflammatory polyarthropathy	0.002	0.998	0.000
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.000	0.998	0.002
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.002	0.998	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations